Ben Around

20 Comments

    • It's Official: Renewable Energy Tax Credits Here to Stay [view article]
      Someone forgot to tell Goldman;

      Solar: Goldman Turns Cautions; Fears Over Supply; Spreading Concerns On Impact Of Tight Credit
      Posted by Eric Savitz
      Solar stocks are trading sharply lower this morning after Goldman Sachs analyst Michael Molnar declared he has become cautious on the solar group, “as less generous subsidies combined with a wave of supply pose a real risk.”

      Molnar asserts in a research note that the risk of oversupply in the solar market “will soon become a reality as considerably less generous demand subsidies take hold just as a wave of supply and tight financing hit the market.” He thinks that “liberal subsidies of the past in markets like Germany and Spain are unlikely to be replicated in the future givne fears of their ultimate cost in a bad world economy.”

      As supply increases, he contends, prices will have to “adjust strongly downward to generate demand.” He thinks that trend will lead to below-consensus estimates for module manufacturers and compressed valuations for stocks in the sector.

      Molnar today cut his rating on First Solar to a Conviction Sell from Buy, slashing his price target to $103 from $365. For SunPower (SPWRA) he goes to Sell from Buy, with a target of $43, down from $100. He also cuts his target on Evergreen Solar (ESLR) to $4.50 from $10.50.

      He sharply reduced estimates for all three of those companies. For FSLR, he now sees $3.62 next year, and $5.92 in 2010, down from $3,75 and $7.13. For SPWRA, he sees $1.22 and $2.47, down from $1.27 and $2.63. For ESLR, he goes to $1.64 and $2.92, down from $1.72 and $2.87.

      Oct 07 10:51 AM
    • Time to Buy Elan? [view article]
      I think the market over reacted to bad news and it is time to buy below 11. Aug 04 09:50 AM
    • Watch for More Coming Biotech Acquisitions [view article]
      The writer failed to mention Elan. The recent bad news has pounded the PPS to a rediculous $10 that makes them a easy target for a tokeover. I would bet, I am buying at this level, that we will see a bid from BIIB to get Elan on the cheap.

      Ichan wants to get BIIB to sell themselves but if they owned all of Elan they would be a much stronger company.

      Aug 03 09:34 AM
    • Elan, Wyeth's Alzheimer Drug News Doesn't Please Investors [view article]
      The market reacted like elan is done. The MS drug continues to grow. The crohn disease treatment is not approved or disproved yet.

      I think at 19 this is a buy again.

      Jul 31 09:17 AM
    • Ford Shareholders Face High Potential for Pain [view article]
      The writer failed to mention his position in Ford stock. I assume he is short.

      He failed to include the class B shares held by the family and the fact that a bankruptcy would wipe them out. He also forgot about the 6.5 mil shares held by Kerkorian.

      I look at Ford as a long term buy with a very low probability of a chapter 11. The issue is to find a good entrypoint. I would expect to see F test the 4.5 point in the future and that would be a good time to buy and hold.

      Jul 28 08:49 AM
    • InterDigital/Samsung ITC Case: Waiting for a Decision [view article]
      The market reaction to any negative news must be looked at and reviewed in light of past performance. In this case I believe that this drop is a buying op and should be acted on. This company below 20 is a buy.

      Just my opinion. I have been wrong before. But I did buy on Tuesday.
      Jul 09 09:29 AM
    • Immunogen and Seattle Genetics: Verging on an Inflection Point [view article]
      Very interesting article.
      I have been in and out of imgn for years and watch it track from 3-6, usually with some justification of the price variations from external influences.
      This latest drop on tuesday (June 3) completely baffles me. I look at it as a buy in again opportunity since I can't see any other reason other than small investor interest.

      Any in comments on Tuesday's action?       Jun 04 09:12 AM
    • General Discussion on CYTR
      Cytr is more than a holding company.
      Value of RXII in CYTR shareprice = $ 0.63 with RXII @ $9.98.

      And then you might want to factor in any CYTR products.

      biz.yahoo.com/bw/08060......

      CYTR 52 week range. 0.71 - 4.70

      Close Friday, $0.88
      Do yourself a favor and buy CYTR.       Jun 02 09:03 AM
    • Why is Wall Street Ignoring ImmunoGen? [view article]
      I agree, but I also am a long time long waiting for vindication of my decision to buy.

      Hope we will get noticed.       May 16 02:32 PM
    • Isis Pharmaceuticals Panic Overdone [view article]
      I agree with the writer. Overreaction has opened a buying opportunity.

      Bought it at 11.5 sold at 16 and now will buy it again next week,

      It looks like ISIS is a range stock that moves between these limits untill some blockbuster deal is announced

      So I will not fight it, I will just buy again.

      Apr 26 08:40 AM
    • Left-for-Dead Syntax-Brillian Should Jump on Bullish Note [view article]
      Now if they just issue the financial reports we might get the monkey off our back.

      The shorts better remember;
      When you shorta stock your best outcome is 100% gain if the company goes BK.
      Your loss is unlimited if the stock starts going up.

      LOOK At the PPS now.

      Apr 22 10:09 AM
    • Are the Changes at Syntax-Brillian Material? [view article]
      sad to say I must agree that the burden of old data has weighed the stock down. Even sadder is the fact that I gambled and am now stuck in a waiting pattern.

      They must put out the financials . bad news is baked in so get it done.

      Apr 08 10:08 AM
    • Under The Radar News - Tuesday [view article]
      Regarding Syntax;
      Interesting how you single out BRLC in the paragraph. What leads you to make the comment about without any research into the state of the company in light of the revised financing?

      Do you have a position in the stock? I assume you are short in BRLC since you fail to mention your position.

      Remember full disclosure?

      Mar 12 10:17 AM
    • InterDigital: Risky Play with Huge Potential Upside [view article]
      IDCC is an interesting stock and I have 'played' it for years. It has proven quite good at moving in a range of 16-30 and I have been using that for my trades.
      I am not too sure of any possible aquisition by Qualcom because I recall a poison pill that they had set up to protect the company from a takeover.

      But I am in it now, waiting for it to get back in favor, but the whole market is punishing a lot of good companies.

      Mar 11 11:03 AM
    • Will Syntax-Brillian Survive? [view article]
      I am waiting to hear your take on today's activity.

      In case you missed it, up 35% on 6.2 million shares.

      Mar 03 08:47 PM
Loading...
Symbols:
Authors:
Quick Links:
Contribute an Article Become a Seeking Alpha Contributor

Transcripts

More Transcripts»